Hospitals & Healthcare News

This section covers the managerial aspects in the Healthcare industry.

Center Point Clinical Services Signs Partnership Agreement with ContraVir Pharmaceuticals

Thursday, June 30, 2016

Center Point Clinical Services provider of specialty clinical research solutions including the signature Clinical Trials Research Pharmacist CTRP solution announced today that it is renewing its partnering agreement with ContraVir Pharmaceuticals Inc NASDAQ CTRV a biopharmaceutical company focused o..

Shire says ADHD drug meets main goal of study

Thursday, June 30, 2016

Irish drugmaker Shire Plc said a study testing an experimental drug to treat attentiondeficit disorder met the main goal bringing the drug one step closer to approval in the United States The company39s shares were up 3 percent at 4381 pence at 1252 GMT 852 am ET on the London Stock Exchange on Wed..

Tesaro's ovarian cancer drug study succeeds, shares soar

Thursday, June 30, 2016

Tesaro Inc said its experimental ovarian cancer drug niraparib met the main goal of prolonging survival in patients without the disease worsening in a latestage trial sending its shares to a record high The Waltham Massachusettsbased company39s shares more than doubled to 77 About 22000 women are ..

Merck and Moderna Announce Strategic Collaboration to Advance Novel mRNA-Based Personalized Cancer Vaccines

Thursday, June 30, 2016

Merck known as MSD outside the United States and Canada and Moderna Therapeutics today announced a strategic collaboration and license agreement to develop and commercialize novel messenger RNA mRNAbased personalized cancer vaccines The collaboration will combine Mercks established leadership in imm..

Kitov's Lead Drug KIT-302 Achieves Manufacturing Milestone Ahead of Planned NDA Filing with U.S. FDA

Wednesday, June 29, 2016

Kitov Pharmaceuticals an innovative biopharmaceutical company focused on latestage drug development announced today that Dexcel Pharma Kitov39s manufacturing partner has successfully completed an initial stability study for its lead drug candidate KIT302 This achievement follows Kitov39s announcemen..

Gilead wins U.S. nod for drug for all types of hepatitis C

Wednesday, June 29, 2016

US health regulators on Tuesday approved a combination drug by Gilead Sciences Inc that is the first available treatment for all six major forms of hepatitis C advancing the company39s leadership in the field and sending its shares up more than 4 percent Gilead said in a separate statement that it ..

Infinity Regains Worldwide Rights to Duvelisib Following Mutual Agreement with AbbVie to end Collaboration

Wednesday, June 29, 2016

Infinity Pharmaceuticals Inc announced that AbbVie Inc has exercised its right to end its collaboration with Infinity to develop and commercialize duvelisib an investigational oral dual inhibitor of phosphoinositide3kinase PI3Kdelta and PI3Kgamma The companies had been in discussions regarding a pot..

U.S. panel backs claim Lilly diabetes drug cuts cardiac death

Wednesday, June 29, 2016

Eli Lilly Co and Boehringer Ingelheim should be allowed to claim that their diabetes drug Jardiance cuts the risk of cardiovascular death an advisory panel to the US Food and Drug Administration concluded on Tuesday The FDA is not obliged to follow the advice of its advisory committees but typical..

Mayne Pharma announces Acquisition of U.S. Generic Product Portfolio from Teva and Allergan

Tuesday, June 28, 2016

Mayne Pharma is pleased to announce that it has entered into a binding agreement to acquire a portfolio of US generic products Portfolio from Teva and Allergan for cash consideration of 652 million The Portfolio consists of 37 approved products and 5 FDA filed products in attractive markets with lim..

Pfizer to invest $350 million in China biotech hub, first in Asia

Tuesday, June 28, 2016

Pfizer Inc will invest 350 million to build a biotech center in China the latest in a series of moves by pharma industry giants to set up shop in the world39s no 2 drugs market with the aim of securing faster approvals for their products The facility in eastern Hangzhou region Pfizer39s first biot..

GW Pharma says cannabis-based epilepsy drug meets main goal

Tuesday, June 28, 2016

British drug developer GW Pharmaceuticals Plc said its experimental cannabisderived epilepsy drug met the main goal to reduce frequency of seizures in a latestage study Shares of the company were up about 21 percent at 611 pence at 1133 GMT 733 am ET on the London Stock Exchange GW Pharma39s USlist..

Roche anticipates quicker U.S. approval for new MS drug

Tuesday, June 28, 2016

Roche39s new multiple sclerosis MS drug could be approved in the United States this year earlier than previously forecast the Swiss drugmaker said on Tuesday after winning the US regulator39s priority review status for the medicine The US Food and Drug Administration FDA and the European Medicines ..

Zhejiang Hisun Pharmaceutical unit passes FDA approval

Monday, June 27, 2016

Zhejiang Hisun Pharmaceutical Co Ltd Says its unit receives ANDA approval for its irbesartan tablets from US Food and Drug Administration Says company39s unit will be able to sell its irbesartan tablets in the United States after receiving the FDA approval Source reuterscom ..

Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition

Monday, June 27, 2016

Jazz Pharmaceuticals plc announced that the waiting period under the HartScottRodino Antitrust Improvements Act of 1976 as amended HSR with respect to its proposed acquisition of Celator Pharmaceuticals Inc expired effective June 24 2016 at 1159 pm Eastern Daylight Time As previously announced on M..

Zhejiang Hisoar Pharmaceutical to buy stake in Hunan-based co for 105 mln yuan

Monday, June 27, 2016

Zhejiang Hisoar Pharmaceutical Co Ltd Says it to buy 25 percent stake in a Hunanbased new material co from two individuals and a Hengyangbased limited partnership Says transaction price 105 million yuan Source reuterscom ..

Pfizer Completes Acquisition of Anacor Pharmaceuticals

Saturday, June 25, 2016

Pfizer Inc today announced that it has completed its acquisition of Anacor Pharmaceuticals Inc Under the terms of the transaction each outstanding share of Anacor common stock has been converted into the right to receive 9925 net in cash without interest but subject to required withholding of taxes ..

FDA panel to vote whether diabetes drug cuts cardiac death

Saturday, June 25, 2016

An advisory panel to the US Food and Drug Administration will be asked to vote next week on whether a diabetes drug made by Eli Lilly Co and Boehringer Ingelheim cuts the risk of cardiovascular death according to documents posted on the agency39s website on Friday The documents were published ahea..

Takeda Revises Collaboration Agreement with Amgen, Returning the Development and Commercialization Rights of Molecules / Products for Japan

Friday, June 24, 2016

Takeda Pharmaceutical Company Limited today announced revisions on an existing collaboration agreement under which Takeda had rights to develop and commercialize multiple molecules products from Amgens pipeline for the Japanese market By the revisions such rights for molecules products including A..

Antares Pharma Announces Settlement of Patent Litigation for Key Alliance Business Product

Friday, June 24, 2016

Antares Pharma Inc announced that Teva Pharmaceuticals USA Inc has settled the patent litigation with AstraZeneca Pharmaceuticals LP AstraZeneca AB and Amylin Pharmaceuticals LLC AstraZeneca relating to AstraZenecas US Patent Nos 6858576 6872700 6956026 7297761 6902744 7521423 and 7741269 and AstraZ..

Sun Pharma bets on new products to boost U.S. skincare products growth

Friday, June 24, 2016

India39s largest drugmaker Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative US dermatology business its US chief said The world39s fifthlargest maker of generic drugs was the first among its Indian peers to enter..

TOP